153 related articles for article (PubMed ID: 6426402)
1. [Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Mukai M; Yamazaki Y; Amano H; Hiura T; Oda S; Namiki S; Nakajima K; Nagao K
Gan To Kagaku Ryoho; 1984 May; 11(5):1071-7. PubMed ID: 6426402
[TBL] [Abstract][Full Text] [Related]
2. [Preoperative OMF therapy for gastric cancer--examination of macroscopical effect in comparison with histological effect].
Mukai M; Hiura T; Yamazaki Y; Namiki S; Nagao K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1801-7. PubMed ID: 6820884
[TBL] [Abstract][Full Text] [Related]
3. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
4. [Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Mukai M; Ryu S; Kikuchi T; Ariga T; Nagashima T; Koh Z; Yamazaki Y; Odaka M; Satoh H; Nagao K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):880-6. PubMed ID: 3920972
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative cancer chemotherapy for gastric cancer].
Fujimoto S; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Kurihara M; Ohta M; Udagawa I
Gan To Kagaku Ryoho; 1985 May; 12(5):1010-8. PubMed ID: 3922306
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer].
Fujii T; Yokomori T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):265-9. PubMed ID: 1899548
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of unresectable Borrmann's type IV stomach cancer].
Kurihara M; Izumi T; Sasaki Y; Maruyama T; Miyasaka K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2468-77. PubMed ID: 6418075
[TBL] [Abstract][Full Text] [Related]
10. [Seven patients with stage IVb advanced gastric cancer who were treated with preoperative chemotherapy].
Yamanaka N; Morisaki T; Nakamura K; Ogawa T; Uchiyama A; Noshiro H; Kuroiwa T; Chijiiwa K; Tanaka M
Gan To Kagaku Ryoho; 2000 Mar; 27(3):459-63. PubMed ID: 10740641
[TBL] [Abstract][Full Text] [Related]
11. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
12. [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].
Sakuramoto K; Okajima K; Iga C; Nishimura J; Toyoda M; Kawashima Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3795-9. PubMed ID: 2512860
[TBL] [Abstract][Full Text] [Related]
13. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890
[TBL] [Abstract][Full Text] [Related]
14. [The significance of endoscopic treatment of early gastric cancer].
Nashimoto A; Maeda C; Sasaki K; Muto T
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):655-63. PubMed ID: 3412299
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
Kanabe S; Tamakuma S; Mimura K; Hiraide H; Mochizuki H; Tamaki K; Kurokawa T; Kadota T; Hatsuse K; Kawano M
Gan No Rinsho; 1985 Nov; 31(14):1805-9. PubMed ID: 3936946
[TBL] [Abstract][Full Text] [Related]
16. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1850-63. PubMed ID: 3929694
[TBL] [Abstract][Full Text] [Related]
17. [Pathological evaluation of neoadjuvant chemotherapy with low-dose FP therapy for advanced gastric cancer].
Takano S; Oda K; Koda K; Seike K; Takiguchi N; Miyazaki M
Gan To Kagaku Ryoho; 2007 Apr; 34(4):555-8. PubMed ID: 17431341
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
Nio Y; Nakamoto K; Tanaka A; Kikuchi S; Henmi K
Nihon Gan Chiryo Gakkai Shi; 1980 Apr; 15(2):161-5. PubMed ID: 7400644
[No Abstract] [Full Text] [Related]
19. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
[TBL] [Abstract][Full Text] [Related]
20. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
Tamada R; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Nakajima T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):716-22. PubMed ID: 3103540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
